Evidence map›Paper›PMID 41083462›Full record

ArticleCell death discovery2025

Chemically induced dimerization of GSDMD C-terminal domain blocks GSDMD N-terminal domain-mediated pyroptosis.

Jixuan Xu, Miaoran Fu, Yamin Xing, Wulong Liang, Guangyuan Li, Ting Zhang, Mengxue Li, Chunxiao Gao, Zhanfeng Yang, Yuming Fu and 4 more

Abstract read
In one paragraph

Article in Cell death discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jixuan XuDepartment of Gastrointestinal & Thyroid Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Miaoran FuDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yamin XingMarshall B. J. Medical Center, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wulong LiangHenan International Joint Laboratory of Glioma Metabolism and Microenvironment Research, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Guangyuan LiDepartment of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Ting ZhangDepartment of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Mengxue LiMarshall B. J. Medical Center, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chunxiao GaoDepartment of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhanfeng YangDepartment of Gastrointestinal & Thyroid Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yuming FuDepartment of Gastrointestinal & Thyroid Surgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Min ZhangDepartment of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zisen ZhangDepartment of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Pengyuan ZhengMarshall B. J. Medical Center, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiufeng ChuDepartment of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China. chuxiufeng831031@gmail.com.ORCID http://orcid.org/0000-0002-4878-5834

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GSDMD is a pyroptosis executioner in which the C-terminal domain completely inhibits the pore-forming ability of the N-terminal domain. Caspase cleavage separates GSDMD into the free C-terminal fragment (GD-CT) and the free N-terminal fragment (GD-NT). Although GD-CT retains the ability to bind with GD-NT, it can no longer completely disable GD-NT, allowing the latter to oligomerize and form nano-sized pyroptotic pores in the plasma membrane. In this study, we report that GD-CT is strictly confined to the cytoplasm, whereas GD-NT is transported to the plasma membrane. Additionally, GD-CT undergoes rapid degradation via the 26S proteasome pathway. Therefore, we propose that the spatial separation and rapid turnover of GD-CT limit its efficacy in blocking GD-NT-mediated pyroptosis. Given these properties of GD-CT, we engineered an efficient pyroptosis blocker "FKBP-GD-CT". This chimera protein incorporates a myristoylation motif, which confers plasma membrane translocation capability, and an FKBP12F36V domain, which enables dimerization in response to the chemical inducer AP20187. This is the first report utilizing chemical-induced dimerization technology to modulate pyroptosis levels.

Identifiers

PMID41083462
PMCPMC12518871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.